Israeli vaccine scores top safety profile, to launch phase 2b/3 trial
The vaccine is currently being evaluated against the new COVID-19 Omicron variant.
A BRILIFE COVID-19 vaccination at Jerusalem’s Hadassah-University Medical Center during trials last year.(photo credit: OLIVIER FITOUSSI/FLASH90)ByMAAYAN JAFFE-HOFFMANUpdated:
